Stratagene Refutes Third Wave s Patent-Infringement Lawsuit Over PCR Reagents | GenomeWeb

Stratagene said last week that a patent infringement lawsuit Third Wave filed against it on Wednesday is without merit.

“We are surprised that Third Wave would file this lawsuit before discussing with us the differences in the two companies’ technologies,” said Joseph Sorge, Stratagene’s chairman and CEO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.